Author:
Hong Tae Hee,Bang Yeong Hak,Joe Cheol Yong,Hwang Soohyun,Lee Boram,Lee Naeun,Park Sehhoon,Jung Hyun-Ae,Sun Jong-Mu,Ahn Jin Seok,Ahn Myung-Ju,Choi Yoon-La,Lee Se-Hoon
Subject
Pulmonary and Respiratory Medicine,Oncology
Reference25 articles.
1. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Planchard;Ann Oncol,2018
2. Therapy for Stage IV non-small-cell lung cancer without driver alterations: ASCO and OH (CCO) joint guideline update;Hanna;J Clin Oncol,2020
3. Non-small cell lung cancer, version 3.2022, NCCN Clinical Practice Guidelines in Oncology;Ettinger;J Natl Compr Canc Netw,2022
4. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer;Reck;N Engl J Med,2016
5. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial;Herbst;Lancet,2016
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献